MedTrace Logo

MRI Features in Neoadjuvant Treatment Decisions for Patients With Rectal Cancer

NCT05609149 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 480

Last updated 2022-11-08

No results posted yet for this study

Summary

This study investigates whether risk criteria based on MRI features could identify a cohort of patients with a good prognosis among those recommended for preoperative treatment by NCCN guidelines to avoid preoperative treatment with the likely good survival outcomes by primary surgery and more accurately indicate the response to the treatment and predict prognosis after neoadjuvant treatmen than radiographic TNM staging in the patients who received neoadjuvant therapy.

Conditions

Interventions

PROCEDURE

total mesorectal excision

patients must underwent total mesorectal excision

Sponsors & Collaborators

  • Sun Yat-sen University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-30
Primary Completion
2022-11-01
Completion
2022-11-02

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05609149 on ClinicalTrials.gov